Search
Returning search results with filters:
Remove filter for
Last updated: April 2021
Remove filter for
Last updated: 2021
Remove filter for
Type: Health professional risk communication
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 3 of 3 items.
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
AlertHealth professional risk communication | 2021-04-28
Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-04-26
Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia
AlertHealth professional risk communication | 2021-04-26